Versant Capital Management »

Neuropace shares owned by Versant Capital Management

Quarter-by-quarter ownership of Neuropace (NPCE) shares owned by Versant Capital Management from 13F filings

Historical chart of Versant Capital Management investment in Neuropace

Tip: Access up to 7 years of quarterly data

All positions including Neuropace held by Versant Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neuropace by Versant Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $762 48 15.90

More positions owned by Versant Capital Management

Microsoft Stock (MSFT)
Avantis International Equity Etf Etf (AVDE)
Flexshares Tr Mornstar Upstr Etf (GUNR)
Dimensional U.s. Core Equity 2 Etf Etf (DFAC)
Avantis Emerging Markets Equity Etf Etf (AVEM)
Ishares S&p Global Energy Etf (IXC)
Dimensional International Core Equity 2 Etf Etf (DFIC)
Vaneck Gold Miners Etf Etf (GDX)
Dimensional Emerging Markets Core Equity 2 Etf Etf (DFEM)
Avago Technologies Stock (AVGO)
Apple Stock (AAPL)
Nvidia Corp Stock (NVDA)
Ishares Gold Trust Micro Etf Of Benef Interest Etf (IAUM)
Global X Fds Global X Ftse Greece 20 Etf Etf (GREK)
Vanguard Total Stk Mkt Etf (VTI)

View all positions for Versant Capital Management

Top funds holding Neuropace

Polar Capital Holdings
Soleus Capital Management
Morgan Stanley
First Light Asset Management
BlackRock
OrbiMed Advisors
Driehaus Capital Management
Vanguard Capital Management
Deutsche Bank Aktiengesellschaft
Armistice Capital
Geode Capital Management
FMR
State Street Corporation
Silvercrest Asset Management Group
Northern Trust

View all funds holding Neuropace